System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Livenow

Terminal Asset View

stockNASDAQ

MLYS

$26.19-2.96%

Mineralys Therapeutics Inc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

22Overripe

Live Analysis Active

Company Mission

Mineralys Therapeutics is a biotechnology company that creates new medications to treat high blood pressure. They conduct clinical trials to test whether their drugs are safe and effective for patients. The company aims to eventually sell these approved treatments to healthcare providers, generating revenue from prescription sales.

MLY

Industry Context

Biotechnology companies develop new medical treatments, often facing years of testing before potential approval. The sector experiences significant price swings around clinical trial results and regulatory decisions, as investors anticipate future revenue from successful drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

75Matrix

Market Momentum

36.4— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

-2.96%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MLYS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:59 PM UTC

As-of 03-14-2026 16:44 UTC

Develops drugs to treat high blood pressure and makes money by selling these medicines to hospitals and pharmacies.

Weekly price swings are getting much tighter, suggesting the stock is coiling for a potential larger move soon.

Biotech sector volatility often precedes FDA decisions, creating opportunities when companies like this approach key milestones.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...